Codexis (CDXS) Non Operating Income (2011 - 2026)

Codexis (CDXS) recorded quarterly Non Operating Income of -$1.3 million in Q1 2026, up 19.17% quarter-over-quarter from -$1.6 million in Q4 2025, and down 36.94% on a YoY basis from -$2.0 million in Q1 2025.

Codexis (CDXS) Non Operating Income (2011 - 2026) Analysis & Trends

Codexis' Non Operating Income history runs 16 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

  • In Q1 2026, Non Operating Income fell 36.94% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$5.2 million (up 52.3% YoY), while the FY2025 annual figure was -$4.8 million, up 53.69% from the prior year.
  • Non Operating Income was -$1.3 million for Q1 2026 at Codexis, up from -$1.6 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $216000.0 in Q3 2022 to a low of -$8.3 million in Q4 2023.
  • Historically, Non Operating Income has averaged -$1.7 million across 5 years, with a median of -$984000.0 in 2025.
  • The sharpest annual moves came in 2022 and 2023: Non Operating Income surged 96.59% in 2022, then slumped 31992.31% in 2023.
  • A 5-year view of Non Operating Income shows it stood at -$26000.0 in 2022, then plunged by 31992.31% to -$8.3 million in 2023, then jumped by 52.4% to -$4.0 million in 2024, then jumped by 59.82% to -$1.6 million in 2025, then gained by 19.17% to -$1.3 million in 2026.
  • The last three Non Operating Income figures came in at -$1.3 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 5.75 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 444,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - 9.35 Mn
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn -1.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.29 Mn
Dec 31, 2025 -1.60 Mn
Sep 30, 2025 -1.29 Mn
Jun 30, 2025 -984,000.00
Mar 31, 2025 -942,000.00
Dec 31, 2024 -3.97 Mn
Sep 30, 2024 -4.92 Mn
Jun 30, 2024 -985,000.00
Mar 31, 2024 -516,000.00
Dec 31, 2023 -8.34 Mn
Sep 30, 2023 -3.90 Mn
Jun 30, 2023 -9,000.00
Mar 31, 2023 -25,000.00
Dec 31, 2022 -26,000.00
Sep 30, 2022 216,000.00
Jun 30, 2022 -63,000.00
Mar 31, 2022 -3,000.00
Dec 31, 2021 228,000.00
Sep 30, 2021 983,000.00
Jun 30, 2021 23,000.00